Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 302, Issue 2, pp 217–226 | Cite as

Investigations on the structure-activity relationships of verapamil

  • R. Mannhold
  • R. Steiner
  • W. Haas
  • R. Kaufmann


An investigation was carried out towards a qualitative and quantitative structure-activity relationship of verapamil based on an analysis of the frequency-dependent negative inotropic action exerted in cat papillary muscles by various groups of verapamil derivatives.

  1. (1)

    Substituents of the benzene ring near the asymmetric carbon atom and the isopropyl group were found to be no essential substituents for the frequency-dependent negative inotropic acition of verapamil but to have a strong influence on the potency of the drug.

  2. (2)

    Both the tertiary amino nitrogen and the two benzene rings are essential for the frequency-dependent negative inotropic action of verapamil.

  3. (3)

    The molecular importance of the N-methyl group is probably based on steric effects.

  4. (4)

    Investigations of the verapamil derivative H 1 revealed that a quaternization of the drug is followed by a total loss of effectiveness.

  5. (5)

    No significant correlation of the biological activity of verapamil derivatives with the partition coefficient P has been obtained.

  6. (6)

    Hansch analysis with verapamil derivatives of group A (= diferent substitution of the benzene ring near C*) shows that the variance of biological activity can be optimally correlated to a combination of the Hammett constant and the molar volume. Hansch analysis of group B (= exchange of isopropyl group) led to the conclusion that hydrophobic effects are responsible for the influence of the isopropyl substituent.


Key words

Verapamil Inotropic effects Cat papillary muscle Structure-activity relation Hansch analysis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bayer, R., Hennekes, R., Kaufmann, R., Mannhold, R.: Inotropic and electrophysiological actions of verapamil and D 600 in mammalian myocardium. I. Pattern of inotropic effects of the racemic compounds. Naunyn-Schmiedeberg's Arch. Pharmacol. 290, 49–68 (1975a)Google Scholar
  2. Bayer, R., Kaufmann, R., Mannhold, R.: Inotropic and electrophysiological actions of verapamil and D 600 in mammalian myocardium. II. Pattern of inotropic effects of the optical isomers. Naunyn-Schmiedeberg's Arch. Pharmacol. 290, 69–80 (1975b)Google Scholar
  3. Bayer, R., Rodenkirchen, R., Ehara, T., Mannhold, R.: Comparative studies of inotropic and electrophysiological effects of “slow channel inhibitors” in isolated mammalian cardiac muscle. Naunyn-Schmiedeberg's Arch. Pharmacol. Suppl. 293, R21 (1976)Google Scholar
  4. Bleeker, A.: The mechanism of the cardiodepressive effect of (±)-verapamil (Isoptin®). Thesis, Amsterdam 1977Google Scholar
  5. Craig, P. N.: Interdependence between physical parameters and selection of substituent groups for correlation studies. J. Med. Chem. 14, 680–684 (1971)Google Scholar
  6. Exner, O.: Dipole moments in organic chemistry, p. 33. Stuttgart: Thieme Verlag 1975Google Scholar
  7. Fujita, T., Iwasa, J., Hansch, C.: A new substituent constant, π, derived from partition coefficients. J. Am. Chem. Soc. 86, 5175–5180 (1964)Google Scholar
  8. Hansch, C., Fujita, T.: ϱ-σ-π analysis. A method for the correlation of biological activity and chemical structure. J. Am. Chem. Soc. 86, 1616–1626 (1964)Google Scholar
  9. Hansch, C., Leo, A., Unger, S. H., Kim, K. H., Nikaitani, D., Lien, E. J.: “Aromatic” substituent constants for structure-activity correlations. J. Med. Chem. 16, 1207–1216 (1973)Google Scholar
  10. Hansch, C., Muir, R. M., Fujita, T., Maloney, P. P., Geiger, F., Streich, M.: The correlation of biological activity of plant growth regulators and chloromycetin derivatives with Hammett constants and partition coefficients. J. Am. Chem. Soc. 85, 2817–2824 (1963)Google Scholar
  11. Hansch, C., Steward, A. R., Anderson, S. M., Bentley, D. L.: The parabolic dependence of drug action upon lipophilic character as revealed by a study of hypnotics. J. Med. Chem. 11, 1–11 (1968)Google Scholar
  12. Hellenbrecht, D., Lemmer, B., Wiethold, G., Grobecker, H.: Measurement of hydrophobicity, surface activity, local anaesthesia and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine β-adrenergic blocking agents. Naunyn-Schmiedeberg's Arch. Pharmacol. 277, 211–226 (1973)Google Scholar
  13. Kaufmann, R., Lab, M. J., Hennekes, R., Krause, H.: Feedback interaction of mechanical and electrical events in the isolated mammalian ventricular myocardium (cat papillary muscle). Pflügers Arch. 324, 100–123 (1971)Google Scholar
  14. Kubinyi, H.: Quantitative structure-activity relationships. IV. Nonlinear dependence of biological activity on hydrophobic character: a new model. Arzneim.-Forsch. 26, 1991–1997 (1976)Google Scholar
  15. Leo, A., Hansch, C., Church, C.: Comparison of parameters currently used in the study of structure-activity relationships. J. Med. Chem. 12, 766–771 (1969)Google Scholar
  16. Mannhold, R., Bayer, R.: Towards a structure-activity relationship of “slow channel inhibitors”. Comparative studies of inotropic patterns exerted by some derivatives of verapamil. Naunyn-Schmiedeberg's Arch. Pharmacol. Suppl. 293, R83 (1976)Google Scholar
  17. McFarland, J. W.: On the parabolic relationship between drug potency and hydrophobicity. J. Med. Chem. 13, 1192–1196 (1970)Google Scholar
  18. McFarland, J. W.: On the understanding of drug potency. Prog. Drug. Res. 15, 123–146 (1971)Google Scholar
  19. Staab, H. A.: Einführung in die theoretische organische Chemie. 4. Auflage, p. 216. Weinheim/Bergstrasse: Verlag Chemie 1970Google Scholar
  20. Taft, jr., R. W.: Separation of polar, steric, and resonance effects. In: Newman, M. S.: Steric effects in organic chemistry, p. 586, New York. Wiley & Sons 1956Google Scholar
  21. Topliss, J., Costello, R. J.: Chance correlations in structure-activity studies using multiple regression analysis. J. Med. Chem. 15, 1066–1068 (1972)Google Scholar
  22. Unger, S., Hansch, C.: On model building in structure-activity relationships. A reexamination of adrenergic blocking activity of β-halo-β-arylalkylamines. J. Med. Chem. 16, 745–749 (1973)Google Scholar

Copyright information

© Springer-Verlag 1978

Authors and Affiliations

  • R. Mannhold
    • 1
  • R. Steiner
    • 1
  • W. Haas
    • 2
  • R. Kaufmann
    • 1
  1. 1.Lehrstuhl für Klinische PhysiologiePhysiologisches Institut der Universität DüsseldorfDüsseldorfGermany
  2. 2.Institut für Physiologische Chemie I der Universität DüsseldorfDüsseldorfGermany

Personalised recommendations